Alto Neuroscience, Inc. (ANRO) vs Janux Therapeutics, Inc. (JANX)
Alto Neuroscience, Inc. and Janux Therapeutics, Inc. are both Biotechnology companies. Alto Neuroscience, Inc. and Janux Therapeutics, Inc. are of similar size ($1.1B and $1.0B). Alto Neuroscience, Inc. has the higher net margin (0.00% vs −427.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Alto Neuroscience, Inc. leads on 6 and Janux Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ANRO | JANX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (598.15%) | 0.00% |
| Net margin | 0.00% | (427.47%) | 0.00% |
| Free cash flow margin | 0.00% | (174.69%) | 0.00% |
| Return on equity | (49.17%) | (10.70%) | (57.72%) |
| Return on assets | (40.90%) | (10.06%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack